At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 25 Aug 2003 No development reported - Preclinical for Type-2 diabetes mellitus in USA (unspecified route)
- 19 Sep 2001 Preclinical development for Type-2 diabetes mellitus in USA (Unknown route)